Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 36% Potential Upside Amid Promising CNS Innovations 8 July 2025
LivaNova PLC (LIVN) Stock Analysis: Exploring a 33.89% Potential Upside and Analyst Consensus 8 July 2025
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Report: A 41.73% Potential Upside in the Healthcare Sector 8 July 2025
Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 30.92% Upside Potential in the Healthcare Sector 8 July 2025
Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A Strong Buy with a 141% Potential Upside 8 July 2025
Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling a Potential 125.88% Upside in the Biotech Arena 8 July 2025
Sotera Health Company (SHC) Stock Analysis: Exploring a 27% Potential Upside in the Healthcare Sector 8 July 2025
BioLife Solutions, Inc. (BLFS) Stock Analysis: A Healthcare Play with 43% Upside Potential 8 July 2025
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Eyeing a 34.94% Upside with Innovative Urology Solutions 8 July 2025
Addus HomeCare Corporation (ADUS) Stock Analysis: Unlocking a 23.35% Upside Potential in the Healthcare Sector 8 July 2025
Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 31.79% Potential Upside 8 July 2025
Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 69% Upside Potential with Strong Buy Ratings 8 July 2025
Disc Medicine, Inc. (IRON): Analyst Consensus and 84% Upside Potential Ignite Investor Interest 8 July 2025
Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating a 3.11% Potential Upside with Strategic Insights 8 July 2025
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Significant Upside Potential with an 87% Increase Forecasted 8 July 2025
Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 126.82% Potential Upside Amidst Strong Buy Ratings 8 July 2025
Indivior PLC (INDV) Investor Outlook: Exploring a 22% Potential Upside with Robust Analyst Confidence 8 July 2025
Hercules Plc Training 2,000 Workers to Help Solve the UK Infrastructure Skills Crisis (Video) 17 November 2025
Firering Strategic Minerals $1M Ricca Settlement Injects Momentum into Lithium Strategy (Video) 14 November 2025
ICG Enterprise Trust: Mid-Teen Growth and a Strong Pipeline Signal Resilience (Video) 11 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video) 6 November 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership 11 November 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Arbuthnot Banking – 6 Percent Dividend and Robust Credit Quality Highlights Shore Capital 24 October 2025
Emerging Markets investment trust outperforms, supported by mining exposure (LON:FEML) 7 January 2026
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Smithson Investment Trust PLC (SSON.L) Stock Analysis: Navigating High RSI and Minimal Dividend Yield 8 January 2026
Supermarket Income REIT PLC ORD (SUPR.L): A Stable Dividend Yield of 7.59% with Modest Upside Potential 8 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Promising 108.68% Potential Upside 8 January 2026
SERCO GROUP PLC ORD 2P (SRP.L) Stock Analysis: Unpacking a 52-Week High Amidst Analyst Mixed Signals 8 January 2026
SIRIUS REAL ESTATE LD ORD NPV (SRE.L) Stock Analysis: Exploring a 24% Potential Upside for Investors 8 January 2026
